Fig. 2.

FGF9 activated FAK, ERK, and AKT pathways in LLC cells. Western blot analysis and quantification of protein expression of p-FAK, total FAK, p-ERK1/2, total ERK1/2, p-AKT, total AKT, p-JNK, total JNK, p-p38, and total p38 in LLC cells treated with 0 (Control) or 50 ng/ml FGF9 for 0.25, 12, 24, 48 and 72 h, respectively, are illustrated. Quantification values are represented as the mean ± SEM; n=3. The data were analyzed by two-way ANOVA with Sidak's multiple comparisons post-tests. *p<0.05 and ***p<0.001 vs. the Control group at each time point.